慢病毒载体介导IκB激酶-α(IKKα)基因RNA干扰转基因小鼠的制备

IκB激酶-α(IKKα)的功能与淋巴形成和乳腺发育相关,在乳腺肿瘤中观察到IKKα蛋白的过量表达.应用小鼠受精卵卵周隙注射慢病毒载体的方式,建立IKKα基因RNAi转基因小鼠模型,为在体内研究IKKα基因的生物学功能及其与肿瘤发生的关系创造条件.实验构建了针对IKKα基因RNAi(剔降)的慢病毒载体,并将载体导入小鼠受精卵卵周隙,获得携带该载体的转基因小鼠模型,经PCR鉴定首建鼠阳性率为15%.转基因小鼠外周血细胞IKKαmRNA表达量明显降低.初步表型观察分析,IKKα基因RNAi小鼠发育正常,进一步的分析工作正在进行中.     

慢病毒介导的牛生长素基因对小鼠胚胎发育的研究

生长素是促进动物生长发育所必需的激素之一。本研究探索牛生长激素(bovine growth hormone,bGH)对小鼠胚胎发育的影响。将牛生长激素基因连接到慢病毒载体(Lenti-CMV-EF1-eGFP)形成Lenti-CMV-bGH/EF1-eGFP,重组病毒经293T细胞包装后直接感染小鼠胚胎和G1胚胎干细胞(embryonicstemcells,ESCs)。阳性表达的胚胎经体外培养,发育到囊胚期的胚胎进行胚胎移植,为直接感染组。感染的小鼠G1胚胎干细胞注射到正常昆明白小鼠囊胚制作嵌合胚胎后进行胚胎移植,为嵌合体组。分别解剖3只妊娠15d的直接感染组和嵌合组的小鼠,观察受体小鼠妊娠情况。结果发现,在1-细胞期感染胚胎,感染效率可达(74.7±6.7)%,在2-细胞期连续感染,感染效率为(79.4±5.7)%,两组感染方法的效率没有显著差异(P>0.05)。1次和2次感染胚胎发育和正常胚胎之间没有显著差异((87.6±3.5)%,(85.4±6.3)%VS(83.0±5.5)%,P>0.05)。所有移植的胚胎没有发育到足月,解剖妊娠15d的小鼠,发现直接感染组没有妊娠,嵌合组胎盘发育正常,但胚胎部分已经死亡和被吸收。因此,本研究证明bGH对小鼠附着前胚胎发育没有影响,但影响小鼠胚胎附着后的发育。这为后期bGH的研究提供参考。     

慢病毒载体介导的绿色荧光蛋白转基因标记法研究猪嵌合体制作

目的:通过建立慢病毒载体感染猪胚胎体系实现胚胎标记,进而研究不同发育阶段猪孤雌胚胎之间的嵌合能力,为进一步研究猪早期胚胎发育以及细胞分化奠定基础.方法:首先,通过显微注射的方法把2×109I.U./ml、2×108I.U./ml和2×107I.U./ml三个梯度的表达绿色荧光的慢病毒载体分别注射到猪1-细胞胚胎和2-细胞胚胎的透明带下,进行胚胎的GFP转基因标记,在荧光显微镜下观察比较卵裂率、阳性胚胎率、囊胚率、阳性囊胚率和囊胚细胞数.然后,采用凹窝聚合法对同步发育胚胎在不同阶段(2-细胞,4-细胞,8-细胞)进行嵌合,2-细胞胚胎与不同发育阶段(2-细胞、4-细胞、8-细胞)胚胎进行嵌合以及2-细胞胚胎卵裂球互换制作嵌合体胚胎,发育到囊胚时在荧光显微镜下检测胚胎的嵌合状态.结果:2×109I.U./ml的慢病毒感染猪2-细胞胚胎组中,体外受精和孤雌胚胎感染阳性率( 80.00％、76.36％)和阳性囊胚率(90.74％、89.56％)都显著高于其它滴度组(P＜0.05),另外,慢病毒感染的两种胚胎与对照组对卵裂率、囊胚率和囊胚细胞数三个指标没有显著影响(P＞0.05).2-细胞胚胎之间嵌合囊胚率和2-细胞卵裂球互换嵌合囊胚率( 53.85％、62.50％)显著高于2-细胞胚胎与4-细胞胚胎的嵌合率(18.60％,P＜0.05),在同步发育胚胎中8-细胞胚胎之间的嵌合率(75.00％)高于4-细胞胚胎之间和2-细胞胚胎之间的嵌合率( 65.00％、53.80％).结论:2×109I.U./ml的慢病毒感染2-细胞期胚胎效率最高,另外,慢病毒感染对猪胚胎发育没有明显影响.8-细胞间的嵌合率比较高;发育同步胚胎间的嵌合率高于发育非同步胚胎间的嵌合率.     

绵羊胞内单精子注射技术

本文的主要目标是建立绵羊胞内单精子注射技术(intracyioplasmic sperm injection,ICSI)。并且尝试了ICSI技术生产绵羊转基因胚胎的可能性。实验1比较了绵羊卵母细胞孤雌激活的3种化学方法。结果显示,Ionomvcin/3 h/6-dimethylaminopurine(6-DMAP)和Ionomycin激活胚的卵裂率(71.7%和91.8%)和囊胚率(17.4%和11%)显著(P<0.01)高于Ca~(2+)激活胚(18.4%和0)。Ionomycin/3 h/6-DMAP激活胚的囊胚发育形态和比例相对较高。实验2中,活精子注射至卵母细胞质后,用Ionomycin/3 h/6-DMAP激活,排出第二极体(PB2)的71枚ICSI胚胎用SOFaaBSA溶液培养,卵裂率为71.8%(51/71),显著(P<0.01)高于体外受精(41.4%,IVF)和阴性对照胚胎(30.2%,sham-ICSI)。培养7天后,sham-ICSI组没有囊胚生成;ICSI和IVF胚胎的囊胚率分别为7.0%(5/71)和16.1%(9/56),两者差异不显著(P>0.05)。这些ICSI囊胚在冷冻前后均能孵化,显示初步建立了绵羊ICSI技术。另外,我们探索了ICSI技术生产转基因胚胎的可能性,-20℃冻融1次的死精子与pEGFP-N1质粒共注射,33枚2-细胞期ICSI胚胎中,2枚可见GFP蛋白。其中1枚停止发育,另外1枚继续发育至16-细胞期,仍然可见GFP基因的表达。4枚解冻的ICSI囊胚手术移植给2只发情同期化受体绵羊,60天时,B超未见怀孕。本文初步结果表明,ICSI技术生产转基因绵羊有可能性,需深入研究。     

猪克隆胚胎激活方法优化与转人溶菌酶基因克隆猪的生产

为了提高转基因克隆效率和获得转人溶菌酶基因克隆猪,研究了不同电激活参数和化学辅助激活方法对猪克隆胚胎和孤雌胚胎体外发育的影响.结果发现:电场强度会显著影响克隆胚胎的融合率和体外发育能力(P<0.05),电脉冲次数对克隆胚胎体外发育促进作用不显著(P>0.05),而相同电激活条件下克隆胚胎和孤雌胚胎的体外发育能力变化趋势不同;电激活后再利用放线菌酮+细胞松弛素B(CHX+CB)处理4 h能显著提高克隆胚胎的囊胚率(P<0.05),而用二甲基氨基嘌呤(6-DMAP)处理没有提高克隆胚胎囊胚率(P>0.05),但6-DMAP或CHX+CB处理均可显著提高孤雌胚胎的囊胚率(P<0.05).上述结果表明,最佳的孤雌激活条件并不一定是克隆胚胎的最佳激活条件.本研究中猪克隆胚胎的最佳激活方法为1.6 kV/cm、100μs、2次直流电脉冲间隔100μs,再辅以CHX+CB处理4 h.利用优化的激活条件成功获得了乳腺特异表达人溶菌酶的转基因猪,为猪转基因育种奠定了基础.     

奶牛体细胞核移植胚胎产业化生产条件优化北大核心CSCD

通过优化高产奶牛体细胞克隆胚胎体外生产技术条件,制备高质量的奶牛克隆胚胎,旨在提高奶牛体细胞核移植产业化应用效率。就受体卵母细胞去核方法、不同年龄供体牛细胞来源、血清饥饿与否以及不同气相组成培养等条件对奶牛体细胞克隆胚胎生产效率的影响进行了研究和探讨。结果表明,虽然荧光染色辅助去核和盲吸法的去核率、囊胚发育率分别为100%、24.83%和92.44%、28.26%,两者之间无显著差异(P>0.05),但盲吸法操作简单、效率高;不同年龄来源供体牛的细胞系构建的克隆胚胎的囊胚发育率分别为31.43%、25.68%,两者之间没有显著差异(P>0.05);经血清饥饿和未饥饿供体细胞重构的克隆胚胎囊胚发育率分别为24%、29.9%,两者之间没有显著差(P>0.05);富氧和低氧气相培养的克隆胚胎的囊胚发育率分别为28.26%、31.55%,两者之间差异不显著(P>0.05),低氧气相组成更有利于囊胚的发育。根据上述结果,奶牛体细胞核移植胚胎(克隆胚胎)的产业化生产条件为:供体细胞无需进行同期饥饿处理,直接注入到盲吸去核后的受体卵子透明带下构建克隆胚胎,融合后的克隆胚胎在密封的混合三气(5%CO2-5%O2-90%N2)的气相组成下进行体外培养,能保持稳定的囊胚发育率。     

小鼠精子注入兔卵母细胞受精研究

利用显微操作仪将小鼠精子注入家兔卵母细胞的胞质内和透明带下,对鼠兔异种精卵互作和异种受精胚胎的发育进行了研究,并对注射精子的数量及卵的体外成熟时间等影响鼠兔异种显微受精的因素进行了探讨,结果如下:(1)将小鼠精子分别注入兔卵胞质内和透明带下,均能激活兔卵母细胞,导致精核解聚和原核形成;(2)小鼠精子注入兔卵胞质内和透明带下受精,杂种胚胎体外培养能发育到8-细胞期;(3)鼠兔异种受精4-细胞胚胎染色体标本制备观察结果表明,它们为正常二倍体;(4)鼠兔异种受精4-细胞胚胎的超微结构观察结果表明,它们极近似兔正常4-细胞胚胎的超微结构;(5)将小鼠精子注入兔卵透明带下,注射5—10个精子组卵的受精率(32.4%)和卵裂率(16.2%)均高于注射单个精子组的,但二组间差异不显著(P>0.05);DM 15%NCS液中体外成熟培养11—12h兔卵透明带下注入1—2个小鼠精子后的受精率(42.3%)和卵裂率(30.8%)均高于体外成熟培养24—25h组的,但二组间差异未达到显著水平(P>0.05)。     

通过双原核显微注射提高转基因小鼠研制效率的实验研究

目的建立高效的转基因小鼠制备技术,为开展遗传工程动物模型研究奠定技术基础。方法通过向小鼠受精卵原核中注入不同浓度的DNA分子,筛选最适注射用DNA浓度;将K14/hCTLA4-Ig基因表达载体分子通过显微注射分别导入小鼠受精卵雌、雄原核,并设立单原核注射对照组;利用输卵管腹壶部穿刺移植法将注射后的小鼠受精卵移植于同期发情的受体母鼠;利用PCR对出生的转基因首建小鼠进行筛选。结果最适DNA分子浓度为10ng/μl;在单、双原核注射组胚胎2细胞卵裂率分别为52.3%(132/253)和45.0%(108/240),差异有显著性(P<0.05);注射胚胎移植后体内存活率分别为18.1%(24/132)和16.7%(18/108),差异无显著性;转基因首建小鼠阳性率分别为3/24和5/18,转基因阳性小鼠占总注射胚胎的比例为1.2%(3/253)和2.08%(5/240),差异有极显著性(P<0.01)。结论尽管双原核注射对胚胎的2细胞卵裂率有一定影响,但通过双原核注射可有效提高转基因小鼠的制备效率。     

猪胞浆内单精子注射研究进展

胞浆内单精子注射将体外受精和显微操作技术相结合,已成功应用于哺乳动物受精机理研究,家畜性控胚胎生产,动物转基因等领域。综述了猪胞浆内单精子注射的主要影响因素,包括卵母细胞体外成熟和预处理、精子的选择和处理、注射卵的人工激活以及操作技术的改进,为进一步提高猪胞浆内单精子注射的效率以及该技术的应用提供参考。     

慢病毒载体法制备红色荧光蛋白转基因小鼠

目的利用慢病毒介导的转基因方法制备红色荧光蛋白（mRFP）转基因小鼠,并建立转基因小鼠的技术平台。方法将携带mRFP基因的慢病毒注入ICR鼠单细胞受精卵卵周隙以感染受精卵,胚胎移植进假孕母鼠以获得仔代鼠,然后应用小动物活体成像仪、体视荧光显微镜和PCR等鉴定并获得mRFP转基因鼠。结果移植卵周隙注射有慢病毒的胚胎40枚给2只假孕母鼠,共获得仔鼠6只;利用体视荧光显微镜检测mRFP表达,在蛋白水平证实6只F0代中,2只（R3和R4）鼠耳高表达mRFP,其余的弱表达mRFP（R1、R2和R5）或荧光强度（R6）与野生型ICR鼠无明显差别,而DNA水平检测证实,6只F0代中,5只（R1、R2、R3、R4和R5）基因组中整合有外源转基因hUb-mRFP,预示基因型鉴定结果很好验证了体视荧光显微镜鉴定结果。此外,mRFP转基因首建鼠基因组中整合的mRFP基因可稳定遗传和表达。结论建立了慢病毒法快速制备转基因小鼠的技术平台,这为针对不同基因建立相应转基因小鼠以实现恒定或条件性的转基因过表达或RNA干涉（RNAi）,并进而在体内解析相应基因功能和建立人类疾病模型等奠定了坚实基础。     

A new method to efficiently produce transgenic embryos and mice from low-titer lentiviral vectors

Vector injection into the perivitelline space has emerged as the standard delivery method to transduce lentivirus to mammalian oocytes or one-cell embryos, but its application is limited by the need for high titers of lentivirus. Herein we developed a new method by using a Piezo impact micro-manipulator for injecting low titer of lentivirus into the subzonal space of two-cell embryos or the perivitelline space of one-cell embryos that were shrunk with a highly concentrated sucrose solution. The survival rate of embryos was greater than 98% using this micromanipulation strategy, which was increased compared to the normal one-cell embryo injection method. More than 90% of injected embryos were GFP positive after subzonal injection of a lentivirus vector carrying the GFP gene with titers of 2 × 10⁸ I.U./ml. Even when a low titer of lentivirus (2 × 10⁶ I.U./ml) was used, 53.26% and 40.85% transgenic embryos were obtained after two-cell embryonic injection and one-cell sucrose treated embryonic injection, respectively. The GFP-positive rates were also greater than in the conventional method of injecting one-cell embryos (25.39%). In addition, blastocysts from the two-cell embryo injection group displayed stronger GFP fluorescence than the one-cell embryo injection groups treated with or without the sucrose solution. Increased expression of GFP suggests that the embryos obtained from this injection method have higher exogenous gene expression levels compared to previous methods. Therefore, in contrast with the traditional injection method, we have demonstrated a simplified and efficient lentivirus-mediated gene transfer method based on a low-titer virus preparation.     

小鼠精子注入兔卵母细胞受精研究

The methods of intracytoplasmic sperm injection (ICSI) and subzonal injection (SUZI) were used to study heterologous fertilization and embryonic development between the mouse and the rabbit. Results were as follows: 1. The mouse sperm nuclei decondensed and formed pronuclei following microinjection into cytoplasm and perivitelline space (PVS) of rabbit oocytes; 2. The hybrid embryos developed to the stage of 8-cell when cultured in vitro; 3. The karyotype analysis showed a normal complement of rabbit oocyte and mouse sperm chromosomes in the 4-cell hybrid embryos; 4. The ultrastructure of 4-cell hybrid embryos was similar to that of normal 4-cell rabbit embryos; 5. The fertilization rate (32.4%) and cleavage rate (22.2%) when 5-10 mouse spermatozoa were injected were higher than those of injection of a single spermatozoon into PVS of the rabbit oocyte, but the difference was not significant (P > 0.05). The fertilization rate (42.3%) and cleavage rate (30.8%) in rabbit oocytes in vitro matured for 11-12 h were higher than those in the oocytes which were in vitro matured for 24-25 h following microinjection of 1-2 mouse spermatozoa into PVS, but the difference was not significant (P > 0.05).     

Manipulation and In Vitro Maturation of Xenopus laevis Oocytes,Followed by Intracytoplasmic Sperm Injection,to Study Embryonic Development

Amphibian eggs have been widely used to study embryonic development. Early embryonic development is driven by maternally stored factors accumulated during oogenesis. In order to study roles of such maternal factors in early embryonic development, it is desirable to manipulate their functions from the very beginning of embryonic development. Conventional ways of gene interference are achieved by injection of antisense oligonucleotides (oligos) or mRNA into fertilized eggs, enabling under- or over-expression of specific proteins, respectively. However, these methods normally require more than several hours until protein expression is affected, and, hence, the interference of gene functions is not effective during early embryonic stages. Here, we introduce an experimental system in which expression levels of maternal proteins can be altered before fertilization. Xenopus laevis oocytes obtained from ovaries are defolliculated by incubating with enzymes. Antisense oligos or mRNAs are injected into defolliculated oocytes at the germinal vesicle (GV) stage. These oocytes are in vitro matured to eggs at the metaphase II (MII) stage, followed by intracytoplasmic sperm injection (ICSI). By this way, up to 10% of ICSI embryos can reach the swimming tadpole stage, thus allowing functional tests of specific gene knockdown or overexpression. This approach can be a useful way to study roles of maternally stored factors in early embryonic development.     

Enhanced transgenesis by intracytoplasmic injection of envelope-free lentivirus

We demonstrate enhanced transgenesis in mice by intracytoplasmic injection of envelope-free lentivirus. Envelope-free lentivirus carrying the green fluorescent protein (GFP) gene under the control of the ubiquitin promoter (LVU-GFP) was microinjected into the cytoplasm of mouse zygotes prior to embryo transfer. Ninety-seven percent (31/32) of the adult mice were confirmed transgenic by PCR and Southern blot analysis; all founder mice express GFP when tail snips were examined by fluorescent microscopy prior to genomic DNA extraction. Transgene insertion numbers ranging from 1 to 32 were revealed by Southern blot analysis. Germline transmission was confirmed by the presence of transgene in F1 offspring. As expected, a lower transgenic rate (2.2%; 1/46) resulted when envelope-free LVU-GFP was microinjected into the perivitelline space (PVS) because cell recognition followed by membrane fusion between the viral envelope and the target cell is prerequisite for successful infection by envelope viruses. Here we demonstrate the competence of envelope-free lentivirus in establishing stable gene integration by germline transgenesis in mice at high efficiency, by intracytoplasmic viral injection (INVI) of envelope-free lentivirus into mouse zygotes.     

Fertilization of bovine oocytes after microsurgical injection of spermatozoa

The objective of this study was to compare the fertilization rate of bovine oocytes matured in vitro (22, 25 or 28 hours) and in vivo (30 to 35 hours after standing estrus) following the microinjection of a single spermatozoon. A single motile spermatozoon was injected into the perivitelline space (Experiments 1 to 9), and a single immotile spermatozoon was injected into the ooplasm (Experiments 10 to 15). A single ejaculate of frozen-thawed semen was used throughout. The spermatozoa were injected either without treatment or after treatment with heparin (100 mug/ml), or Ca ionophore A23187 (0.1 muM), or co-cultured for 5 hours with bovine oviduct epithelial cells (BOEC), or they were co-cultured for 5 hours with BOEC and immobilized by freezing and thawing twice without cryoprotectant, or they remained untreated. Oocytes were placed in a droplet of hyperosmotic solution of 0.1 M sucrose in PBS to enlarge the perivitelline space (Experiments 1 to 9) or in PBS (Experiments 10 to 15). Small amounts of polyvinyl pyrrolidone (PVP) without spermatozoa were injected as a control for parthenogenetic activation. After injection, oocytes were incubated in Medium 199 for 22 hours at 39 degrees C, and they were stained with 1% aceto-orcein and examined for evidence of fertilization or parthenogenetic activation. Low rates (9 to 11%) of fertilization resulted from injection into the perivitelline space of oocytes matured for 22 hours in vitro irrespective of spermatozoa treatment. Fertilization rates were higher in oocytes matured in vivo after injection into either perivitelline space (66%) or ooplasm (74%) than in oocytes matured in vitro (9 to 44% fertilization). Surprisingly, in oocytes matured in vivo, there was no difference in the proportions fertilized by spermatozoa injection into ooplasm and parthenogenetically activated by injection of medium alone (74 and 66%, respectively).     

Birth of mice after nuclear transfer by electrofusion using tail tip cells

Mice have been successfully cloned from cumulus cells, fibroblast cells, embryonic stem cells, and immature Sertoli cells only after direct injection of their nuclei into enucleated oocytes. This technical feature of mouse nuclear transfer differentiates it from that used in domestic species, where electrofusion is routinely used for nuclear transfer. To examine whether nuclear transfer by electrofusion can be applied to somatic cell cloning in the mouse, we electrofused tail tip fibroblast cells with enucleated oocytes, and then assessed the subsequent in vitro and in vivo development of the reconstructed embryos. The rate of successful nuclear transfer (fusion and nuclear formation) was 68.8% (753/1094) and the rate of development into morulae/blastocysts was 40.8% (260/637). After embryo transfer, seven (six males and one female; 2.5% per transfer) normal fetuses were obtained at 17.5-21.5 dpc. These rates of development in vitro and in vivo are not significantly different from those after cloning by injection (44.7% to morulae/blastocysts and 4.8% to term). These results indicate that nuclear transfer by electrofusion is practical for mouse somatic cell cloning and provide an alternative method when injection of donor nuclei into recipient oocytes is technically difficult.     

Efficient production of androgenetic embryos by round spermatid injection

Mammalian androgenetic embryos can be produced by pronuclear exchange of fertilized oocytes or by dispermic in vitro fertilization of enucleated oocytes. Here, we report a new technique for producing mouse androgenetic embryos by injection of two round spermatid nuclei into oocytes, followed by female chromosome removal. We found that injection of round spermatids resulted in high rates of oocyte survival (88%). Androgenetic embryos thus produced developed into mid‐gestation fetuses at various rates, depending on the mouse strain used. All the fetuses examined maintained paternally specific genomic imprinting memories. This technique also enabled us to produce complete heterozygous F1 embryos by injecting two spermatids from different strains. The best rate of fetal survival (12% per embryos transferred) was obtained with C57BL/6 × DBA/2 androgenetic embryos. We also generated embryonic stem cell lines efficiently with the genotype of Mus musculus domesticus × M. m. molossinus. Thus, injection of two round spermatid nuclei followed by maternal enucleation is an effective alternative method of producing androgenetic embryos that consistently develop into blastocysts and mid‐gestation fetuses. genesis 47:155–160, 2009. © 2009 Wiley‐Liss, Inc.     

Oocyte activation and parthenogenetic development of bovine oocytes following intracytoplasmic sperm injection.

Development of bovine oocytes after intracytoplasmic sperm injection (ICSI) was investigated. Oocytes were matured for 24-26 h in vitro and injected with isolated sperm heads. When treated with 7% ethanol (v/v) for 5 min, 71.7% of ICSI oocytes were activated as shown by the resumption of meiosis and the formation of female pronuclei. However, 41.5% of injected sperm heads remained condensed at 18-20 h after injection into the ooplasm. The incidence of decondensing sperm and that of male pronuclei at this stage were 15.1% and 26.4%, respectively. A total of 55.5% of oocytes reached the 2-cell stage following sperm head injection and 54.7% after sham-ICSI; these percentages were not significantly different from those following in vitro fertilisation (IVF) (73.1%). The percentage of 2-cell embryos reaching the 8-cell stage following ICSI was 37.5%, and 27.6% after sham-ICSI, which were significantly lower (p < 0.01) than the equivalent percentage following IVF (62.4%). The percentages of parthenogenetic embryos reaching the 2-cell, 4-cell and 8-cell stages following ICSI were 56.4%, 48.9% and 30.0%, respectively. These results indicate that the low rate of normal embryonic development of bovine oocytes following ICSI is largely due to the parthenogenetic activation of the oocytes.